Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 79.80
+1.30 (1.66%)
At close: May 29, 2026
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 328.28 million as of May 29, 2026. Its market cap has increased by 176.66% in one year.
Market Cap
328.28M
Enterprise Value
393.72M
Revenue
78.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
79.80
Market Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 328.28M, an increase of 1,019.39%. That is a compound annual growth rate of 38.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 328.28M | 24.82% |
| Dec 31, 2025 | 263.00M | 76.79% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 435.71M |
| Matricelf | 81.53M |
| Clal Biotechnology Industries | 45.49M |
| BioLineRx | 39.31M |
| BioLight Life Sciences | 33.08M |
| Evogene | 20.61M |
| Can-Fite BioPharma | 20.02M |
| Purple Biotech | 18.65M |